Taris Biomedical tapped Julie Lekstrom Himes to be its chief medical officer and lead its clinical development program.
Urology
Rochester Medical swings to a Q3 net loss
Rochester Medical Corp. posted third-quarter sales of $9 million for the three months ended Sept. 30, down 5.3 percent compared with $9.5 million during the same period last year. The company posted net losses of $229,000 for the quarter, compared with net income of $342,000 during Q3 2008:
Press Release
Rochester Medical Reports Fourth Quarter and Annual Results and Announces Final Medicare Approval for Reimbursement for the FEMSOFT(R) Insert
Augmenix lands $6.1 million in Series B round
Augmenix, the latest life science venture from serial hydrogel entrepreneur Amar Sawhney, landed a second, $6.1 million tranche for a Series B funding round to develop its SpaceOAR radiation oncology polymer product.
Waltham, Mass.-based Augmenix is working on clinical trials for the product, an injectable, degradable polyethylene glycol-based hydrogel designed to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer.
Boston Scientific inks urological diagnostics deal
Boston Scientific Corp. inked a co-marketing deal with Bladder Health Network that will see the medical device-making giant sell BHN’s female urinary incontinence diagnostic tool.
Jackson, Miss.-based BHN makes equipment to measure urinary system function and efficiency in women. Boston Scientific said it will market the system to healthcare providers in the U.S.
MedTech Monday: Are IV bags the next fashion statement?
Turn your post-op recovery into a fashion statement: With designer Olivier Trillon’s concepts, you can choose between an Yves Saint Laurent or Chanel IV bag for your post-op morphine drip.
MassDevice Q&A: Chris LaFarge
Chris LaFarge, president and CEO of MedicaMetrix, is betting on his firm’s ProstaGlove device to change the way doctors track and treat the prostate. The product is essentially a disposable rubber glove armed with sensors LaFarge says will provide a quantitative method for tracking the volume and growth rate of the prostate — the only human organ that never stops growing.